Related Experiment Video

Updated: Aug 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Epidemiology of hepatitis C virus (HCV) infection

Theodore Sy1, M Mazen Jamal

  • 1Division of Gastroenterology, University of California, Irvine, CA 92868, USA.

International Journal of Medical Sciences
|April 15, 2006
PubMed

Insights

Hepatitis C virus infection poses a global health challenge. This review examines current prevalence, genotype data, and risk factors, including intravenous drug use and transfusion transmission, for this often latent disease.

Area of Science:

  • Hepatology and Virology
  • Infectious Diseases Epidemiology

Background:

  • Hepatitis C virus (HCV) represents a significant global healthcare burden.
  • Calculating precise incidence rates is challenging due to the asymptomatic and latent nature of HCV infection.
  • Increasing awareness of transfusion-related transmission and the role of intravenous drug use in HCV spread is evident.

Purpose of the Study:

  • To review current global prevalence data for Hepatitis C virus.
  • To analyze the distribution of Hepatitis C virus genotypes worldwide.
  • To examine the various risk factors associated with Hepatitis C virus transmission.

Main Methods:

  • Literature review of existing studies on Hepatitis C virus prevalence.
  • Analysis of reported genotype data from diverse geographical regions.
  • Synthesis of information on identified risk factors for Hepatitis C virus infection.

Main Results:

  • Global Hepatitis C virus prevalence rates exhibit fluctuations.
  • Intravenous drug use is increasingly recognized as a primary risk factor for HCV transmission.
  • Transfusion-related transmission is a recognized, though often historical, source of infection.

Conclusions:

  • Understanding HCV prevalence and genotypes is crucial for public health strategies.
  • Targeted interventions addressing intravenous drug use are essential for controlling HCV spread.
  • Continued surveillance and research are necessary to manage the global burden of Hepatitis C virus.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...